Jazz Pharmaceuticals JAZZ Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax?
- Jazz Pharmaceuticals (JAZZ) reported other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax of -$200K in Q1 2026.
- How has Jazz Pharmaceuticals's other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax changed year-over-year?
- Jazz Pharmaceuticals's other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax decreased by 150.0% year-over-year, from $400K to -$200K.
- What does other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax mean?
- The portion of hedging gains or losses moved from equity into the income statement this period.
- How do you interpret other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax?
- Indicates the timing and magnitude of realized hedging impacts on the company's reported operating results.
- How does other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax compare across companies?
- Standard for companies that utilize hedge accounting for operational risks.